FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286295087> ?p ?o ?g. }

• W4286295087 endingPage "1536" @default.
• W4286295087 startingPage "1536" @default.
• W4286295087 abstract "1536 Background: In response to rising healthcare costs, several innovative payment strategies have emerged to improve the value and efficiency of healthcare spending. One of these strategies is a shift from volume-based to value-based care (VBC), resulting in the introduction of alternative payment models, innovative provider contracting and new value frameworks. The purpose of this study is to evaluate the impact of a VBC arrangement on total cost of care for chemotherapy patients, specifically cancer-related drug costs, daily hospital inpatient admissions and emergency room visits. Methods: This is a cohort study of chemotherapy patients, in a single state, enrolled in a large national insurer from January 18, 2021, to September 30, 2021. Oncology patients were divided into two groups; the study group consisted of chemotherapy patients receiving care in a VBC arrangement; the control group consisted of chemotherapy patients receiving care at oncology practices not engaged with the insurer in a VBC agreement. The following levers were employed to improve value: digital symptom tracking, biosimilar or lower-cost drug options and NCCN regimen concordance. We defined cancer-related drug costs as the sum of allowed costs paid for medical and pharmacy claims during the study period. Additionally, we averaged the cost per hospital inpatient day and emergency room visit and compared these by group. Results: This study included 1,574 patients, 733 patients in the study group and 841 in the control group. A reduction of 5.1% (a difference of $441) in cancer-related drug costs per member per treatment month (PMPTM) was observed among patients in the study group. Patients in the study group reported 27.8% fewer inpatient days resulting in a savings of $194 PMPTM. Similarly, patients in the study group reported 70.0% fewer emergency room visits resulting in a savings of $59 PMPTM. Conclusions: In this study, chemotherapy patients participating in a shared savings VBC spent less on cancer-related drug costs, hospital inpatient days and emergency room visits through three value levers. Further studies are needed to assess if these results are similar all types of healthcare coverage and to what degree additional value levers further reduce costs. Additionally, the long-term health outcomes of these patients should be assessed." @default.
• W4286295087 created "2022-07-21" @default.
• W4286295087 creator A5005132831 @default.
• W4286295087 creator A5009803061 @default.
• W4286295087 creator A5026716992 @default.
• W4286295087 creator A5036937569 @default.
• W4286295087 creator A5037858207 @default.
• W4286295087 creator A5040346307 @default.
• W4286295087 creator A5040849216 @default.
• W4286295087 creator A5044661937 @default.
• W4286295087 creator A5046545741 @default.
• W4286295087 creator A5046886829 @default.
• W4286295087 creator A5053801045 @default.
• W4286295087 creator A5056105715 @default.
• W4286295087 creator A5064521165 @default.
• W4286295087 creator A5065026748 @default.
• W4286295087 creator A5065371138 @default.
• W4286295087 creator A5069375794 @default.
• W4286295087 creator A5071217924 @default.
• W4286295087 creator A5071909965 @default.
• W4286295087 creator A5084230850 @default.
• W4286295087 creator A5086116655 @default.
• W4286295087 date "2022-06-01" @default.
• W4286295087 modified "2023-10-16" @default.
• W4286295087 title "The impact of an oncology-specific shared savings agreement." @default.
• W4286295087 doi "https://doi.org/10.1200/jco.2022.40.16_suppl.1536" @default.
• W4286295087 hasPublicationYear "2022" @default.
• W4286295087 type Work @default.
• W4286295087 citedByCount "0" @default.
• W4286295087 crossrefType "journal-article" @default.
• W4286295087 hasAuthorship W4286295087A5005132831 @default.
• W4286295087 hasAuthorship W4286295087A5009803061 @default.
• W4286295087 hasAuthorship W4286295087A5026716992 @default.
• W4286295087 hasAuthorship W4286295087A5036937569 @default.
• W4286295087 hasAuthorship W4286295087A5037858207 @default.
• W4286295087 hasAuthorship W4286295087A5040346307 @default.
• W4286295087 hasAuthorship W4286295087A5040849216 @default.
• W4286295087 hasAuthorship W4286295087A5044661937 @default.
• W4286295087 hasAuthorship W4286295087A5046545741 @default.
• W4286295087 hasAuthorship W4286295087A5046886829 @default.
• W4286295087 hasAuthorship W4286295087A5053801045 @default.
• W4286295087 hasAuthorship W4286295087A5056105715 @default.
• W4286295087 hasAuthorship W4286295087A5064521165 @default.
• W4286295087 hasAuthorship W4286295087A5065026748 @default.
• W4286295087 hasAuthorship W4286295087A5065371138 @default.
• W4286295087 hasAuthorship W4286295087A5069375794 @default.
• W4286295087 hasAuthorship W4286295087A5071217924 @default.
• W4286295087 hasAuthorship W4286295087A5071909965 @default.
• W4286295087 hasAuthorship W4286295087A5084230850 @default.
• W4286295087 hasAuthorship W4286295087A5086116655 @default.
• W4286295087 hasConcept C10138342 @default.
• W4286295087 hasConcept C104863432 @default.
• W4286295087 hasConcept C121608353 @default.
• W4286295087 hasConcept C126322002 @default.
• W4286295087 hasConcept C145097563 @default.
• W4286295087 hasConcept C160735492 @default.
• W4286295087 hasConcept C160798450 @default.
• W4286295087 hasConcept C162324750 @default.
• W4286295087 hasConcept C194828623 @default.
• W4286295087 hasConcept C2776694085 @default.
• W4286295087 hasConcept C2778336483 @default.
• W4286295087 hasConcept C2779703844 @default.
• W4286295087 hasConcept C2781413609 @default.
• W4286295087 hasConcept C50522688 @default.
• W4286295087 hasConcept C512399662 @default.
• W4286295087 hasConcept C59491497 @default.
• W4286295087 hasConcept C71924100 @default.
• W4286295087 hasConceptScore W4286295087C10138342 @default.
• W4286295087 hasConceptScore W4286295087C104863432 @default.
• W4286295087 hasConceptScore W4286295087C121608353 @default.
• W4286295087 hasConceptScore W4286295087C126322002 @default.
• W4286295087 hasConceptScore W4286295087C145097563 @default.
• W4286295087 hasConceptScore W4286295087C160735492 @default.
• W4286295087 hasConceptScore W4286295087C160798450 @default.
• W4286295087 hasConceptScore W4286295087C162324750 @default.
• W4286295087 hasConceptScore W4286295087C194828623 @default.
• W4286295087 hasConceptScore W4286295087C2776694085 @default.
• W4286295087 hasConceptScore W4286295087C2778336483 @default.
• W4286295087 hasConceptScore W4286295087C2779703844 @default.
• W4286295087 hasConceptScore W4286295087C2781413609 @default.
• W4286295087 hasConceptScore W4286295087C50522688 @default.
• W4286295087 hasConceptScore W4286295087C512399662 @default.
• W4286295087 hasConceptScore W4286295087C59491497 @default.
• W4286295087 hasConceptScore W4286295087C71924100 @default.
• W4286295087 hasIssue "16_suppl" @default.
• W4286295087 hasLocation W42862950871 @default.
• W4286295087 hasOpenAccess W4286295087 @default.
• W4286295087 hasPrimaryLocation W42862950871 @default.
• W4286295087 hasRelatedWork W120818538 @default.
• W4286295087 hasRelatedWork W2076064454 @default.
• W4286295087 hasRelatedWork W2093961132 @default.
• W4286295087 hasRelatedWork W2166521090 @default.
• W4286295087 hasRelatedWork W2299308758 @default.
• W4286295087 hasRelatedWork W2347614275 @default.
• W4286295087 hasRelatedWork W2384740383 @default.
• W4286295087 hasRelatedWork W2620560209 @default.
• W4286295087 hasRelatedWork W3106263696 @default.
• W4286295087 hasRelatedWork W1540236315 @default.

• next